StockTipsArenaBeta

BUY Medplus Health Services Limited — Keynote Capitals

BUYMedplus Health Services Limited
Medplus Health Services share price target & all analyst calls

byKeynote CapitalsHorizon: NA (inferred 1 year)6 Aug 2025via Institutional / Brokerage Research

Entry₹836.1Inferred
Target₹1,130
Total upside +35.15% (call closed)
Stop lossNot given
At expiry₹690.36 Aug 2026, 3:30 pm
Expired-17.44%
Follow Keynote Capitals for new calls(56% target hit, 145 closed calls)Get alertsWatch MEDPLUS for new buy/sell callsGet alertsSee 2 active Long-term calls on MEDPLUSSee 274 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 6 Aug 2026
0 supporting2 neutral5 opposing
Supports the BUY call (0)

Nothing found in this tip’s window yet.

Neutral / worth noting (2)

The Board of Directors has decided to keep in abeyance the implementation of CAPEX plans, including setting up a Food Park and a Concierge Health & Wellness Services Facility. The company expects no a

NSE · Outcome of Board Meeting·23 Jul · 2w ago

(opens in new tab)

Market Pulse: Key triggers to watch before the July 21 trading session

NewsCnbc-Tv18·20 Jul · 2w ago

(opens in new tab)
Weighs against the BUY call (5)

MedPlus Admits Staff Went 'A Little Overboard' Selling Private-Label Medicines

NewsNdtv-Profit·23 Jul · 2w ago

(opens in new tab)

MedPlus Health shares fall up to 18%, slip below IPO price, dragged by these factors

NewsCnbc-Tv18·22 Jul · 2w ago

(opens in new tab)

MedPlus Health shares tumble 16% after Q1 profit falls 21% YoY. Should you buy, sell or hold?

NewsEt-Markets·22 Jul · 2w ago

(opens in new tab)

MedPlus Shares Fall Over 17% After Q1 Net Profit Declines 21%

NewsNdtv-Profit·22 Jul · 2w ago

(opens in new tab)

MedPlus Health Q1 net profit falls 22% as margins decline despite 22% revenue growth

NewsCnbc-Tv18·21 Jul · 2w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Medplus Health Services

All analyst calls on Medplus Health Services

More from Keynote Capitals

Every call and its outcome